179 related articles for article (PubMed ID: 7721258)
1. Ageing of the hypothalamo-pituitary-testicular axis in men.
Vermeulen A; Kaufman JM
Horm Res; 1995; 43(1-3):25-8. PubMed ID: 7721258
[TBL] [Abstract][Full Text] [Related]
2. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.
Camacho EM; Huhtaniemi IT; O'Neill TW; Finn JD; Pye SR; Lee DM; Tajar A; Bartfai G; Boonen S; Casanueva FF; Forti G; Giwercman A; Han TS; Kula K; Keevil B; Lean ME; Pendleton N; Punab M; Vanderschueren D; Wu FC;
Eur J Endocrinol; 2013 Mar; 168(3):445-55. PubMed ID: 23425925
[TBL] [Abstract][Full Text] [Related]
3. A new look to the andropause: altered function of the gonadotrophs.
Vermeulen A; Deslypere JP; De Meirleir K
J Steroid Biochem; 1989 Jan; 32(1B):163-5. PubMed ID: 2913408
[TBL] [Abstract][Full Text] [Related]
4. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men.
Vermeulen A; Kaufman JM; Deslypere JP; Thomas G
J Clin Endocrinol Metab; 1993 May; 76(5):1140-6. PubMed ID: 8496304
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine regulation of pulsatile luteinizing hormone secretion in elderly men.
Kaufman JM; Deslypere JP; Giri M; Vermeulen A
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):421-30. PubMed ID: 2257245
[TBL] [Abstract][Full Text] [Related]
6. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
Cailleux-Bounacer A; Rohmer V; Lahlou N; Lefebvre H; Roger M; Kuhn JM
Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384
[TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrinological aspects of aging].
Vermeulen A
Verh K Acad Geneeskd Belg; 1994; 56(4):267-80. PubMed ID: 7801702
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.
Wu FC; Tajar A; Pye SR; Silman AJ; Finn JD; O'Neill TW; Bartfai G; Casanueva F; Forti G; Giwercman A; Huhtaniemi IT; Kula K; Punab M; Boonen S; Vanderschueren D;
J Clin Endocrinol Metab; 2008 Jul; 93(7):2737-45. PubMed ID: 18270261
[TBL] [Abstract][Full Text] [Related]
9. Peripheral INSL3 concentrations decline with age in a large population of Australian men.
Anand-Ivell R; Wohlgemuth J; Haren MT; Hope PJ; Hatzinikolas G; Wittert G; Ivell R
Int J Androl; 2006 Dec; 29(6):618-26. PubMed ID: 17014531
[TBL] [Abstract][Full Text] [Related]
10. [Neurohormonal regulation of male gonad function].
Döcke F
Z Gesamte Inn Med; 1979 Oct; 34(20):589-92. PubMed ID: 121496
[TBL] [Abstract][Full Text] [Related]
11. Obesity and testicular function.
Mah PM; Wittert GA
Mol Cell Endocrinol; 2010 Mar; 316(2):180-6. PubMed ID: 19540307
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
[TBL] [Abstract][Full Text] [Related]
13. Changes in the hypothalamic-pituitary-gonadal axis in men after cadaver kidney transplantation and cyclosporine therapy.
Samojlik E; Kirschner MA; Ribot S; Szmal E
J Androl; 1992; 13(4):332-6. PubMed ID: 1399835
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
[TBL] [Abstract][Full Text] [Related]
15. Evidence from the rhesus monkey (Macaca mulatta) for the view that negative feedback control of luteinizing hormone secretion by the testis is mediated by a deceleration of hypothalamic gonadotropin-releasing hormone pulse frequency.
Plant TM; Dubey AK
Endocrinology; 1984 Dec; 115(6):2145-53. PubMed ID: 6437793
[TBL] [Abstract][Full Text] [Related]
16. Management of the cardinal features of andropause.
Mooradian AD; Korenman SG
Am J Ther; 2006; 13(2):145-60. PubMed ID: 16645432
[TBL] [Abstract][Full Text] [Related]
17. Environment, human reproduction, menopause, and andropause.
Vermeulen A
Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):91-100. PubMed ID: 8243411
[TBL] [Abstract][Full Text] [Related]
18. Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients.
Bardin CW; Ross GT; Rifkind AB; Cargille CM; Lipsett MB
J Clin Invest; 1969 Nov; 48(11):2046-56. PubMed ID: 4390462
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: late-onset hypogonadism.
Mahmoud A; Comhaire FH
Nat Clin Pract Urol; 2006 Aug; 3(8):430-8. PubMed ID: 16902519
[TBL] [Abstract][Full Text] [Related]
20. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
